FITC Anti-Human CD62L Antibody[DREG56]

FITC Anti-Human CD62L Antibody[DREG56]

The FITC Anti-Human CD62L Antibody [DREG56] is a highly specific and reliable tool designed for the detection and analysis of CD62L expression in human samples. CD62L, also known as L-selectin, is a cell adhesion molecule that plays a crucial role in the migration and homing of lymphocytes to secondary lymphoid organs. This antibody is conjugated with FITC (fluorescein isothiocyanate), a bright and photostable fluorochrome, enabling easy visualization and quantification of CD62L-positive cells by flow cytometry.

This antibody, clone DREG56, has been extensively validated and characterized for its exceptional specificity and sensitivity in recognizing CD62L. It exhibits minimal cross-reactivity with other related molecules, ensuring accurate and reliable results. The FITC conjugation provides a strong fluorescent signal, allowing for precise identification and enumeration of CD62L-expressing cells in complex biological samples.

The FITC Anti-Human CD62L Antibody [DREG56] is suitable for a wide range of applications, including immunophenotyping, cell sorting, and functional studies. It enables researchers to investigate the role of CD62L in immune responses, inflammation, and various disease states. With its high quality and performance, this antibody is an invaluable tool for scientists and clinicians working in immunology, oncology, and other related fields, facilitating a deeper understanding of lymphocyte trafficking and immune cell dynamics.